Michael Chernis named by MG Magazine as one of “30 Powerful Cannabis Attorneys You Should Know”

Broadly defined, litigation is the process of resolving a dispute between opposing parties through the court system. In business, any relationship–with vendors, suppliers, employees, customers, or competitors–is subject to misunderstanding and miscommunication that can result in litigation. In the burgeoning legal cannabis industry, the opportunity for such occurrences is greatly pronounced.

Matters most often turning up in litigation involve issues such as ownership or partnership disputes, commercial contracts, employment disputes, trademarks and patents, real estate and landlord disputes, product liability, taxes, insurance, and even appellate advocacy, though more rarely than the aforementioned. For each such concern, there are litigating attorneys who specialize in the intricacies.


MICHAEL CHERNIS

Chernis Law Group PC, California
Practice areas: Criminal defense, regulatory law, corporate law, civil litigation
Alma mater: Fordham University Law School
Hard facts: Demonstrating his clients’ compliance with the “collective defense” created by SB420, Chernis has obtained dismissals, reductions of charges, agreements not to file charges, and returns of confiscated goods in a variety of cases. Among the most noteworthy: dismissal of Los Angeles District Attorney charges against a Berkeley manufacturer and return of its cannabis oil cartridges in 2016 and the non-filing and return of goods in a 2014 CO2 manufacturing lab raid and seizure in Riverside County. (ChernisLaw.com)

Michael Chernis

See the full list here: www.mgretailer.com

Tagged with: , , , , , ,
Posted in News

California’s New Batch Testing Requirements

By Michael Jensen, Chernis Law Group

California’s new batch testing requirements are proving difficult to meet for the California cannabis industry. Beginning July 1, 2018, testing requirements for products became fully implemented. Under the new rules, all products must be batch tested for pesticides, microbial impurities, residual solvents, homogeneity, foreign material, and moisture.

The Bureau of Cannabis Control—the regulatory authority for retailers, distributors, and testing laboratories—has started to release weekly data on passing and failing products. The most recent reports from October 9 and 15 are reproduced below. In the October 9 report, of the 16,050 batches tested, 2,684 failed (16.7%). In the October 15 report, of the 16,869 batches tested, 2,804 failed (16.6%).

Diving deeper into the numbers, it is clear that testing compliance is most difficult for manufacturers of edibles, tinctures, and topicals, which have a failing rates of nearly 30%. Additionally, label claims are the most common reason for noncompliance.

Under the title 17 of the California Code of Regulations (CCR), section 40405(a)(4), respective THC and CBD contents for a package must be included on the label. To pass testing for THC and CBD content, the product must test within 10% of the content indicated on the label. Title 16, CCR § 5724(d). Fortunately, inaccurate label claims are curable, and a may be re-labeled by certain distributors. Title 16, CCR § 5303(c).

Navigating the regulated cannabis market in California is becoming more complicated than ever. If you are operating a licensed cannabis business and need assistance with regulatory compliance, Chernis Law Group is ready to assist you.

Posted in News

Michael Chernis is our Latest Featured Speaker!

By Pincus Professional Education

Our latest featured speaker is Michael Chernis from Chernis Law Group!

Michael will be on the faculty panel at our upcoming Recreational and Medical Marijuana Law and Business in California seminar in Los Angeles on November 1-2! Michael first spoke for us at our 2017 Marijuana Law conference, where attendees’ evaluations said he was very informative and gave a fantastic presentation. We are excited to have Michael back!

Michael Chernis is one of California’s premier experts on marijuana legal issues whether it’s criminal, civil, federal, or business related. His law firm, Chernis Law Group P.C. in Santa Monica California, serves the varied needs of collectives, dispensaries, deliveries, cultivators, manufacturers and other medical cannabis clients, including a number of leading cannabis brands. His experience as a federal criminal defense attorney gives him a unique perspective on federal enforcement issues as they pertain to the cannabis industry. As Policy Director of the Los Angeles Cannabis Task Force, he has been at the forefront of driving ballot issues and working with lawmakers to enact changes in the law that will benefit existing and prospective stakeholders.

Posted in News

California Passes SB 1409 Industrial Hemp Bill – What Does It Mean?

By Michael Chernis, Chernis Law Group

On Sunday, September 30, Gov. Brown signed Senate Bill 1409 into law, finally creating a pathway for legal industrial hemp farming in California that will comply with section 7606 of the 2014 Farm Bill (codified at 7 U.S.C. § 5940). While existing California law permitted industrial hemp farming, the activity was, at least practically speaking, limited to established agricultural research institutions or those who could pair up with those institutions to grow hemp for “research.” Additionally, for anyone who wasn’t an established agricultural institution, testing standards were impossibly rigid (only DEA-registered labs could test crops for THC content), seed cultivars (breeds) were limited to those certified before January 1, 2013, and hemp could be farmed only for fiber and oil-seed crop, meaning that CBD extraction was not expressly contemplated. Most importantly, California’s existing hemp law was not compliant with the federal industrial hemp farming requirements created by section 7606 of the 2014 Farm Bill.

SB 1409 amends various sections of the California Food and Agriculture Code (FAC) to change all of this and the definition of industrial hemp under the Health and Safety Code (HSC). Among the changes, S.B. 1409 does the following:

• Authorizes the California Department of Food and Agriculture to create a pilot program and regulations that are compliant with section 7606 of the 2014 Farm Bill (FAC § 81007). This means that farmers will have a pathway to register with their county agricultural commission as soon as the CDFA creates the pilot program.

• Redefines industrial hemp to remove the fiber and oilseed crop limitation (HSC § 11018.5(a).

• Expands the purpose of industrial hemp farming beyond planting for densely planted fiber or oilseed crop (FAC § 81006(a)(1)).

• Allows the Department of Food and Agriculture to determine which types of laboratories may test industrial hemp for compliance with THC requirements (FAC § 81006(d)(5)).

• Eliminates the cutoff date for certification of seed cultivars so that any certified seed may be planted, regardless of when it was certified (FAC § 81002(b)).

• Creates a yearly registration requirement for famers who are not established research institutions to register with the local county agricultural commissioner (FAC § 81003).

• Authorizes clonal propagation of industrial hemp (FAC § 81002(a)).

• Allows ornamental cultivation of industrial hemp (FAC § 81006(b)).

A big takeaway from California’s new hemp farming bill is that extraction of CBD from industrial hemp flowers will now be permitted under California law. This is important in light of the recent statement from the California Department of Public Health stating that hemp-derived CBD and certain other hemp materials in food products was banned. Stay tuned on how the Department of Public Health reacts to SB 1409, as it will undoubtedly cause it to revisit their policy.

If you are interested in industrial hemp farming or extraction activities, please contact Chernis Law Group to discuss further.

Posted in News

Yes, that CBD Product in Whole Foods is (Still) Illegal

By Michael Jensen, Chernis Law Group

On September 21, the “CBD West” trade show descended on Anaheim. Given the city’s historic identification with Disneyland and all things fantasy, the CBD industry could not have selected a better forum to display and sell their products. Along with the mainstreaming of cannabis, hemp-derived cannabidiol, more commonly known as “CBD,” is becoming a staple of health food stores, online retailers, and many other commercial outlets in across the country that one would not mistake for a dispensary. The CBD market is projected to grow exponentially greater than cannabis. While walking the expo floor I viewed (and sampled) a panoply of products infused with CBD, including tinctures, skin patches, drink powders, candies, chocolates, salves, massage oil, cooking oil, and lotions.

CBD is the new rage in the alternative treatment of various health conditions. It is increasing associated with treating serious illnesses, and alleviating ordinary symptoms of illnesses, without creating the high or psychoactive effect of its cannabinoid sister THC. And unlike THC products, which will practically always violate the Federal Controlled Substances Act there is a colorable argument as to why CBD products derived from Industrial Hemp and grown in accordance with the 2014 Farm Bill do not violate the CSA.

But here’s the thing: CBD products, even when derived from Industrial Hemp, are still considered illegal under the Food, Drug & Cosmetic Act (FDCA). This is because CBD is considered an unapproved drug that is currently the subject of clinical investigations. Consequently, CBD cannot be marketed as a drug or dietary supplement and cannot be used as a food additive, since it is considered an adulterant when added to a food product.

Simply put, there is no way to sell any CBD product that is in compliance with the FDCA. Over the past few years, the FDA issued numerous letters to manufacturers of CBD products that market them as either drugs or dietary supplements to treat any number of health conditions. Fortunately, this has been the extent of federal enforcement actions.

Adding to the uncertainty, the California Department of Public Health issued a statement in July 2018 that expressly prohibits adding CBD to food products. This despite the CDPH licensing and regulating manufacturers of cannabis food products that include THC and CBD. And yet, at CBD West, and across the State of California, CBD both food and other products are widely sold.

Between the FDA, DEA, and state agencies in California, the legal landscape is confusing to say the least. The bad news is that, strictly speaking, all products containing CBD are illegal under federal law, and food products containing CBD are also illegal under California law. The good news is that federal and state enforcement has been very limited thus far, making the risk of criminal exposure minimal. Nonetheless manufacturers should tread cautiously in this marketplace and consult with legal counsel whenever marketing and selling products that contain CBD.

Posted in News

Michael Chernis quoted on thestreet.com about CBD Legality

CBD Doesn’t Get You High, But Could Someday Eclipse the Entire Pot Industry

By Annie Gaus, www.thestreet.com

The future of cannabis may not be about getting high.

Pot is a multi-billion dollar industry — where it’s legal, anyway — but some advocates believe that the future of cannabis is actually a non-euphoric derivative that delivers health benefits without getting you high.

This past weekend, scores of entrepreneurs, researchers and health advocates congregated in Anaheim, Calif. for CBD Expo West, a conference devoted to showcasing the booming business of CBD, shorthand for Cannabidiol. In California, where adult use of marijuana is permitted, CBD has been showing up in a fast-growing array of products, from vaporizers and oils to skin balms and gummy bears. And you don’t need to duck into a licensed dispensary to buy it; you can often find CBD at your local corner store.

According to the Brightfield Group, sales of CBD are estimated to reach $22 billion by 2022. And after speaking with exhibitors at CBD Expo, it’s easy to see why: They’re passionate advocates of its potential to soothe pain, anxiety and inflammation without need for pharmaceuticals — and without the high of THC, which not everyone wants.

Read more at: www.thestreet.com

Posted in News

Like Us on Facebook

Follow Us on Facebook

Archives